Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 1, 2013, Pages 74-82

  Stocker, Petra ^a,b   Dehnert, Manuel ^a   Schuster, Melanie ^a   Wichmann, Ole ^a   Delere, Yvonne ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Germany; Human papillomavirus; Knowledge; School students; Vaccination status

Indexed keywords

MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; GERMANY; HUMAN; KNOWLEDGE; MALE; MEASLES; MIGRATION; MUMPS; PAPILLOMAVIRUS INFECTION; PREDICTION; QUESTIONNAIRE; RUBELLA; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; STUDENT ATTITUDE;

GERMANY; HUMAN PAPILLOMAVIRUS; KNOWLEDGE; SCHOOL STUDENTS; VACCINATION STATUS;

ADOLESCENT; BERLIN; DRUG UTILIZATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SCHOOLS; STUDENTS; YOUNG ADULT;

EID: 84874683820     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.22192     Document Type: Article

References (42)

1. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915-27; PMID:17494925; http://dx.doi.org/10.1056/NEJMoa061741.
2. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, et al.; HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301-14; PMID:19586656; http://dx.doi.org/10.1016/S0140-6736(09)61248-4.
3. Abteilung Gesundheit im Landesamt für Umwelt, G.u.V.B., Impfstatus von Mädchen der 10. Klassen: HPV. 2010.
4. Roggendorf H. Erste Erfahrungen zur Akzeptanz der HPV-Impfung. Monatsschr Kinderheilkd 2009; 157:982-5; http://dx.doi.org/10.1007/s00112-009-2012-z.
5. Burns IT, Zimmerman RK. Immunization barriers and solutions. J Fam Pract 2005; 54(Suppl):S58-62; PMID:15623395.
6. Dahlström LA, Tran TN, Lundholm C, Young C, Sundström K, Sparén P. Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden. Int J Cancer 2010; 126:500-7; PMID:19569173; http://dx.doi.org/10.1002/ijc.24712.
7. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010; 126:425-33; PMID:20679306; http://dx.doi.org/10.1542/peds.2009-3500.
8. Das A, Madhwapathi V, Davies P, Brown G, Dearnley E, Spencer A, et al. Knowledge and acceptability of the HPV vaccine by school children and their parents in Birmingham. Vaccine 2010; 28:1440-6; PMID:20005317; http://dx.doi.org/10.1016/j.vaccine.2009.11.041.
9. Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S. Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination. BMC Public Health 2008; 8:368; PMID:18947430; http://dx.doi.org/10.1186/1471-2458-8-368.
10. Ford JL. Racial and ethnic disparities in human papillomavirus awareness and vaccination among young adult women. Public Health Nurs 2011; 28:485-93; PMID:22092458; http://dx.doi.org/10.1111/j.1525-1446.2011.00958.x.
11. Daley EM, Marhefka S, Buhi E, Hernandez ND, Chandler R, Vamos C, et al. Ethnic and racial differences in HPV knowledge and vaccine intentions among men receiving HPV test results. Vaccine 2011; 29:4013-8; PMID:21459176; http://dx.doi.org/10.1016/j.vaccine.2011.03.060.
12. Poethko-Müller C, Kuhnert R, Schlaud M. Vaccination coverage and predictors for vaccination level. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50:851-62; PMID:17514471.
13. Pitts M, Smith A, Croy S, Lyons A, Ryall R, Garland S, et al. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination. Vaccine 2009; 27:2989-93; PMID:19428910; http://dx.doi.org/10.1016/j.vaccine.2009.02.101.
14. Wong LP, Sam IC. Ethnically diverse female university students' knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol 2010; 148:90-5; PMID:19910102; http://dx.doi.org/10.1016/j.ejogrb.2009.10.002.
15. Rondy M, van Lier A, van de Kassteele J, Rust L, de Melker H. Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine 2010; 28:2070-5; PMID:20045095; http://dx.doi.org/10.1016/j.vaccine. 2009.12.042.
16. Das A, Madhwapathi V, Davies P, Brown G, Dearnley E, Spencer A, et al. Knowledge and acceptability of the HPV vaccine by school children and their parents in Birmingham. Vaccine 2010; 28:1440-6; PMID:20005317; http://dx.doi.org/10.1016/j.vaccine.2009.11.041.
17. de Bekker-Grob EW, Hofman R, Donkers B, van Ballegooijen M, Helmerhorst TJ, Raat H, et al. Girls' preferences for HPV vaccination: a discrete choice experiment. Vaccine 2010; 28:6692-7; PMID:20708696; http://dx.doi.org/10.1016/j. vaccine.2010.08.001.
18. Agius PA, Pitts MK, Smith AM, Mitchell A. Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine 2010; 28:4416-22; PMID:20434543; http://dx.doi.org/10.1016/j.vaccine.2010.04.038.
19. Dempsey A, Cohn L, Dalton V, Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011; 29:528-34; PMID:21050904; http://dx.doi.org/10.1016/j.vaccine.2010.10.051.
20. Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 2008; 42:237-42; PMID:18295131; http://dx.doi.org/10.1016/j.jadohealth.2007.08. 022.
21. Roberts SA, Brabin L, Stretch R, Baxter D, Elton P, Kitchener H, et al. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect 2011; 139:400-5; PMID:20334731; http://dx.doi.org/10.1017/S095026881000066X.
22. Gochman DS. Some correlates of children's health beliefs and potential health behavior. J Health Soc Behav 1971; 12:148-54; PMID:5088034; http://dx.doi.org/10.2307/2948522.
23. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q 1984; 11:1-47; PMID:6392204; http://dx.doi.org/10.1177/109019818401100101.
24. Daley EM, Vamos CA, Buhi ER, Kolar SK, McDermott RJ, Hernandez N, et al. Influences on human papillomavirus vaccination status among female college students. J Womens Health (Larchmt) 2010; 19:1885-91; PMID:20815737; http://dx.doi.org/10.1089/jwh.2009.1861.
25. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009; 45:453-62; PMID:19837351; http://dx.doi.org/10.1016/j.jadohealth. 2009.04.021.
26. Freeman VA, Freed GL. Parental knowledge, attitudes, and demand regarding a vaccine to prevent varicella. Am J Prev Med 1999; 17:153-5; PMID:10490061; http://dx.doi.org/10.1016/S0749-3797(99)00063-X.
27. Rosenthal D, Dyson S, Pitts M, Garland S. Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women. Women Health 2007; 45:59-73; PMID:18019286; http://dx.doi.org/10.1300/J013v45n02-04.
28. Chan SS, Cheung TH, Lo WK, Chung TK. Women's attitudes on human papillomavirus vaccination to their daughters. J Adolesc Health 2007; 41:204-7; PMID:17659226; http://dx.doi.org/10.1016/j.jadohealth. 2007.04.011.
29. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010; 171:357-67; PMID:20047978; http://dx.doi.org/10.1093/aje/kwp365.
30. de Bekker-Grob EW, Hofman R, Donkers B, van Ballegooijen M, Helmerhorst TJ, Raat H, et al. Girls' preferences for HPV vaccination: a discrete choice experiment. Vaccine 2010; 28:6692-7; PMID:20708696; http://dx.doi.org/10.1016/j. vaccine.2010.08.001.
31. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, et al.; IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366:991-8; PMID:16168781; http://dx.doi.org/10.1016/S0140-6736(05)67069-9.
32. Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, et al. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin 2009; 5:696-704; PMID:19855170; http://dx.doi.org/10.4161/hv.5.10.9515.
33. Li R, Li Y, Radley D, Liu Y, Huang T, Sings HL, et al. Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and females. Vaccine 2012; 30:4284-91; PMID:22433961; http://dx.doi.org/10.1016/j. vaccine.2012.02.079.
34. Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine 2011; 29:8279-84; PMID:21907257; http://dx.doi.org/10. 1016/j.vaccine.2011.08.106.
35. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004; 364:249-56; PMID:15262102; http://dx.doi.org/10.1016/S0140-6736(04)16674-9.
36. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132:810-9; PMID:10819705.
37. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2005; 113:1005-9; PMID:15515017; http://dx.doi.org/10.1002/ijc.20678.
38. Office of National Statistics Cervical Cancer Screening Programme 2004-2005, 2005.
39. Cervical Screening Wales Annual Report 2005, 2005.
40. Berlin-Brandenburg AS. Bildungsbericht 2010, 2010, Institut für Schulqualität Berlin-Brandenburg und Amt für Statistik Berlin-Brandenburg Potsdam.
41. Dempsey AF, Schaffer S. Middle-and high-school health education regarding adolescent vaccines and human papillomavirus. Vaccine 2010; 28:7179-83; PMID:20801244; http://dx.doi.org/10.1016/j.vaccine.2010.08.066.
42. Schenk L, Ellert U, Neuhauser H. Children and adolescents in Germany with a migration background. Methodical aspects in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50:590-9; PMID:17514443; http://dx.doi.org/10.1007/s00103-007-0220-z.